Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.740 +0.320 (+4.31%)
Streaming Delayed Price Updated: 10:33 AM EDT, Jun 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced... 
From NeoGenomics, Inc.
Via AccessWire
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
Data demonstrates potential of RaDaR to predict clinical response in stage III urothelial cancer FT. MYERS, FL / ACCESSWIRE / April 11, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of... 
From NeoGenomics, Inc.
Via AccessWire
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
NeoGenomics continues to add to its state-of-the-art multiomics solutions in world-class biopharma clinical trial and research services for global pharma companies FORT MYERS, FL / ACCESSWIRE / April... 
From NeoGenomics, Inc.
Via AccessWire
NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
FT. MYERS, FL / ACCESSWIRE / April 8, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to... 
From NeoGenomics, Inc.
Via AccessWire
Why Is NeoGenomics (NEO) Stock Down Today?
Cancer-testing company NeoGenomics is down more than 30% today after lowering earnings expectations. How far will NEO stock fall? 
Via InvestorPlace
NeoGenomics Stock Gets Downgrade After CEO Resigns And Other Negative Updates
NeoGenomics, Inc. 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price... 
Via Benzinga
NeoGenomics Stock Tanks After CEO Exits Amid Sales, Profitability Maelstrom
Shares were hammered after NeoGenomics pulled its full-year outlook. 
Via Investor's Business Daily
Why NeoGenomics Stock Is Plunging Today
Via Benzinga
NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Lost Money in NeoGenomics, Inc.?
From Gibbs Law Group
Via Business Wire
NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – NEO
From The Rosen Law Firm, P.A.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
53 Biggest Movers From Yesterday
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... 
Via Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of NeoGenomics, Inc. (NEO) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of NeoGenomics, Inc. (NEO) Investors
From Kirby McInerney LLP
Via Business Wire
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers IGM Biosciences (NASDAQ:IGMS) shares rose 114.8% to $32.2 during Tuesday's regular session. IGM Biosciences's stock is trading at a volume of 31.6 million... 
Via Benzinga
Stocks Higher as Ukraine-Russia Peace Talks Advance
Optimism is high on Wall Street, as peace talks between Ukraine and Russia seem to advance. 
Via Talk Markets
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday. 
Via Benzinga
Twilio Insider Trading Scandal: 8 Things for TWLO Stock Investors to Know
Twilio (TWLO) stock is on the move Tuesday as the U.S. Securities and Exchange Commission (SEC) weighs in on an insider trading scandal. 
Via InvestorPlace
36 Stocks Moving In Tuesday's Mid-Day Session
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a... 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates
U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.